Medicamen Biotech Ltd Share Price & Stock Analysis

Medicamen Biotech Ltd (BSE: 531146) is a New Delhi, Delhi-based company in the Pharmaceuticals industry. With a market capitalisation of ₹367 Cr, it ranks #2,199 by market cap among the 6,197 Indian listed companies on FinBizNet, and #31 of 63 in Pharmaceuticals. At ₹283.90 (as of 16 Nov 2026), the share price is 36.6% below its 52-week high of ₹447.65 and 33.7% above its 52-week low of ₹212.40. The share price is down 29.5% over one year and up 16.9% over three months.

Key Metrics

Current Price₹283.90
Market Cap₹367 Cr
BSE Code531146
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryBiotechnology and Life Sciences > Pharmaceuticals
P/E Ratio38
Return on Equity4.01%
Return on Assets2.31%
52-Week Range₹212.40 – ₹447.65
1-Year Price Change-29.5%
3-Month Price Change+16.9%
Beta (1Y)0.63
Dividend Yield0.37%
HeadquartersNew Delhi, Delhi
Websitewww.medicamen.com

Latest Quarterly Results — Q2 FY27

Revenue₹55 Cr
Net Profit₹4 Cr
Net Margin7.5%
Basisconsolidated

Figures in ₹ crore, parsed from the company's exchange filing (XBRL).

Medicamen Biotech Ltd Quarterly Revenue and Profit Trend

Medicamen Biotech Ltd reported revenue of ₹55 Cr in Q2 FY27, up 16.2% from ₹47 Cr in Q2 FY26 and up 14.5% from ₹48 Cr in Q1 FY27. It posted a net profit of ₹4 Cr for the quarter, against a net profit of ₹2 Cr in Q2 FY26 (up 94.8%). Across the 7 quarters from Q4 FY25 to Q2 FY27, quarterly revenue ranged from ₹30 Cr (Q4 FY25) to ₹61 Cr (Q4 FY26). The company was profitable in each of these 7 quarters.

QuarterRevenueNet ProfitNet Margin
Q2 FY27₹55 Cr₹4 Cr7.5%
Q1 FY27₹48 Cr₹2 Cr3.9%
Q4 FY26₹61 Cr₹4 Cr7.3%
Q3 FY26₹47 Cr₹2 Cr3.5%
Q2 FY26₹47 Cr₹2 Cr4.5%
Q1 FY26₹43 Cr₹2 Cr3.7%
Q4 FY25₹30 Cr₹2 Cr6.3%

Consolidated figures (₹ crore, XBRL filings).

Shareholding and Delivery

Promoters held 42.57% of Medicamen Biotech Ltd's shares as of Oct 2026, against 40.46% in Dec 2025 (+2.11 percentage points). Delivery averaged 100.0% of traded volume across 15 BSE sessions (21 Oct 2026 – 13 Nov 2026).

About Medicamen Biotech Ltd

Medicamen Biotech Limited, a pharmaceutical company, research, develops, manufactures, markets, sells, and distributes pharmaceutical formulations in India and internationally. The company offers drugs in various forms, including tablet, capsule, syrups, oral solution, and drops. Its products are used in therapeutic areas comprising cancer care, cardiology, CNS, diabetology, anti-infective, anti-malarials, vitamins, antibiotics, and supplements, other generics, and pain management. The company was incorporated in 1993 and is based in New Delhi, India.

Products and Services

1. Pharmaceuticals Formulations-This segment engages in the development and manufacture of pharmaceutical products.

Business Segments

1. Pharmaceuticals Formulations-100%

Medicamen Biotech Ltd vs Peers — Pharmaceuticals

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Abbott India Ltd.₹56,531 Cr36.334.46%₹1,814 Cr-8.1%
Emcure Pharmaceuticals Ltd₹42,344 Cr47.919.57%₹2,820 Cr+73.3%
Ajanta Pharma Limited₹41,474 Cr39.425.39%₹1,794 Cr+27.8%
Piramal Pharma Ltd₹32,600 Crn/m-4.00%₹2,617 Cr+22.8%
RUBICON RESEARCH LIMITED₹28,526 Cr112.319.14%₹576 Cr+162.7%
Caplin Point Laboratories Ltdte₹18,155 Cr28.319.94%₹630 Cr+23.6%
Pfizer Ltd.₹17,811 Cr24.517.16%₹727 Cr-24.2%
Eris Lifesciences Ltd₹17,691 Cr28.318.07%₹892 Cr-17.5%
Medicamen Biotech Ltd₹367 Cr384.01%₹55 Cr-29.5%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Medicamen Biotech Ltd?

Medicamen Biotech Ltd is trading at ₹283.90, with a market capitalisation of ₹367 Cr.

Which sector does Medicamen Biotech Ltd belong to?

Medicamen Biotech Ltd operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Pharmaceuticals).

What are the key financial ratios of Medicamen Biotech Ltd?

Medicamen Biotech Ltd has a P/E of 38 and a return on equity of 4.01%.

What is the stock symbol of Medicamen Biotech Ltd?

Medicamen Biotech Ltd is listed on the BSE under the scrip code 531146.

How has Medicamen Biotech Ltd's share price moved over the past year?

Medicamen Biotech Ltd's share price is down 29.5% over one year and up 16.9% over three months. Its 52-week range is ₹212.40 to ₹447.65.

What were Medicamen Biotech Ltd's latest quarterly results?

In Q2 FY27, Medicamen Biotech Ltd reported revenue of ₹55 Cr and net profit of ₹4 Cr (consolidated, parsed from the company's exchange filing).

How have Medicamen Biotech Ltd's revenue and profit changed over the past year?

Medicamen Biotech Ltd reported revenue of ₹55 Cr in Q2 FY27, up 16.2% from ₹47 Cr in Q2 FY26 and up 14.5% from ₹48 Cr in Q1 FY27.

What is the promoter holding in Medicamen Biotech Ltd?

Promoters held 42.57% of Medicamen Biotech Ltd's shares as of Oct 2026, against 40.46% in Dec 2025 (+2.11 percentage points).

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.